These findings are furthermore consistent with a recent broad bioinformatic analysis of semaphorin expression data in human tumors, which indicated a significant inverse correlation between Sema3C expression and sensitivity to anti-cancer drugs 50. The gene discussed is SEMA3C; the disease is cancer.